Company / Current Liabilities
TELA Bio, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$18.0M
FY2025
5-year range
$10.6M / $18.0M
FY2021-FY2025
Trend
+15.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 7 years, ranging from $7M in FY2020 to $18M in FY2025.
Based on SEC 10-K filings.
$18M in FY2025 with a 5-year CAGR of +22.2%.
Increased from $17M to $18M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +13.2%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +22.2%, indicating consistent growth.
- In FY2025, current liabilities increased 15.2% year-over-year.
- Lowest current liabilities in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.0M | +15.2% |
| FY2024 | $15.6M | -8.1% |
| FY2023 | $17.0M | +36.8% |
| FY2022 | $12.4M | +17.3% |
| FY2021 | $10.6M | +60.1% |
| FY2020 | $6.6M | -1.6% |
| FY2019 | $6.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026